Zobrazeno 1 - 10
of 1 003
pro vyhledávání: '"STEFAN H. HOHNLOSER"'
Autor:
Badder Kattih, Felix Operhalski, Felicitas Boeckling, Florian Hecker, Felix Michael, Mate Vamos, Stefan H. Hohnloser, Julia W. Erath
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundThe subcutaneous implantable cardioverter-defibrillator (S-ICD) has been designed to overcome lead-related complications and device endocarditis. Lacking the ability for pacing or resynchronization therapy its usage is limited to selected p
Externí odkaz:
https://doaj.org/article/ba98c6ba72d044f4b5802c756ec265e2
Autor:
François Philippon, MD, FRCPC, FHRS, FCCS, Gilles E. O’Hara, MD, Jean Champagne, MD, Stefan H. Hohnloser, MD, Michael Glikson, MD, Jörg Neuzner, MD, Philippe Mabo, MD, Xavier Vinolas, MD, Josef Kautzner, MD, Fredrik Gadler, MD, Noa Lashevsky, Stuart J. Connolly, MD, Yan Y. Liu, MSc, Jeff S. Healey, MD
Publikováno v:
CJC Open, Vol 2, Iss 5, Pp 354-359 (2020)
Background: The number of implantable cardioverter defibrillator (ICD) infections is increasing due to an increased number of ICD implants, higher-risk patients, and more frequent replacement procedures, which carry a higher risk of infection. Reduci
Externí odkaz:
https://doaj.org/article/2f9010a036a34b4597810afaa72e93dd
Autor:
Carina Blomström-Lundqvist, Gerald V Naccarelli, David S McKindley, Gregory Bigot, Mattias Wieloch, Stefan H Hohnloser
Publikováno v:
EP Europace. 25:845-854
Aims This post hoc analysis of the ATHENA trial (NCT00174785) assessed the effect of dronedarone on the estimated burden of atrial fibrillation (AF)/atrial flutter (AFL) progression to presumed permanent AF/AFL, and regression to sinus rhythm (SR), c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f792f8bf467a8d0d4645b551b6ebe8e0
https://doi.org/10.1093/europace/euad023
https://doi.org/10.1093/europace/euad023
Autor:
Ziad Hijazi, Christopher B. Granger, Stefan H. Hohnloser, Johan Westerbergh, Johan Lindbäck, John H. Alexander, Matyas Keltai, Alexander Parkhomenko, José L. López-Sendón, Renato D. Lopes, Agneta Siegbahn, Lars Wallentin
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 18 (2020)
Background We compared different methods of estimated glomerular filtration rate (eGFR) and their association with cardiovascular death and major bleeding in 14 980 patients with atrial fibrillation in the ARISTOTLE (Apixaban for Reduction in Stroke
Externí odkaz:
https://doaj.org/article/c55f0fc3f82c42adaf15cbcb564747c9
Autor:
Paulus Kirchhof, Michael D. Ezekowitz, Yanish Purmah, Sonja Schiffer, Isabelle L. Meng, A. John Camm, Stefan H. Hohnloser, Anke Schulz, Melanie Wosnitza, Riccardo Cappato
Publikováno v:
TH Open, Vol 04, Iss 01, Pp e20-e32 (2020)
Introduction This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects of treat
Externí odkaz:
https://doaj.org/article/4684f89640f5438ab6e6f2148ca93bc5
Autor:
William F McIntyre, Jia Wang, Alexander P Benz, Linda Johnson, Stuart J Connolly, Isabelle C Van Gelder, Renato D Lopes, Michael R Gold, Stefan H Hohnloser, Chu Pak Lau, Carsten W Israel, Jorge A Wong, David Conen, Jeff S Healey
Publikováno v:
Europace, 24(7), 1058-1064. Oxford University Press
Aims There is uncertainty about whether and how to perform screening for atrial fibrillation (AF). To estimate the incidence of previously undetected AF that would be captured using a continuous 14-day ECG monitor and the associated risk of stroke. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7baea995541219d4657c35b90addee3e
https://hdl.handle.net/11370/ca9536e1-01db-4a9c-87d0-b25c8e2d04b1
https://hdl.handle.net/11370/ca9536e1-01db-4a9c-87d0-b25c8e2d04b1
Autor:
Josephine Harrington, Anthony P. Carnicelli, Kaiyuan Hua, Lars Wallentin, Manesh R. Patel, Stefan H. Hohnloser, Robert P. Giugliano, Keith A.A. Fox, Ziad Hijazi, Renato D. Lopes, Sean D. Pokorney, Hwanhee Hong, Christopher B. Granger
Publikováno v:
Circulation.
BACKGROUND: There is uncertainty surrounding the use of direct oral anticoagulants (DOACs) in patients with kidney dysfunction. METHODS: Using the COMBINE AF (A Collaboration Between Multiple Institutions to Better Investigate Non-Vitamin K Antagonis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff5206c9320116faae49675a24b92dd8
https://doi.org/10.1161/circulationaha.122.062752
https://doi.org/10.1161/circulationaha.122.062752
Autor:
A. John Camm, Gerald V. Naccarelli, Suneet Mittal, Harry J.G.M. Crijns, Stefan H. Hohnloser, Chang-Sheng Ma, Andrea Natale, Mintu P. Turakhia, Paulus Kirchhof
Publikováno v:
Journal of the American College of Cardiology. 79:1932-1948
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42a25b098490db9d2b718de839bf6a09
https://doi.org/10.1016/j.jacc.2022.03.337
https://doi.org/10.1016/j.jacc.2022.03.337
Autor:
Stefan H. Hohnloser, Nidhi Bhattacharyya, Emily P. Zeitler, Anne B. Curtis, Aysha Malik, Andrew Bogard, John Stewart
Publikováno v:
Europace. 24:1754-1762
Aims Age and sex may impact the efficacy of antiarrhythmic drugs on cardiovascular outcomes and arrhythmia recurrences in patients with atrial fibrillation (AF). We report on a post hoc analysis of the ATHENA study (NCT00174785), which examined cardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e12e13d210650bc2b67787e411cc392
https://doi.org/10.1093/europace/euab208
https://doi.org/10.1093/europace/euab208
Autor:
Georg Nickenig, Róbert Gábor Kiss, Zeki Öngen, Matias Nordaby, Uwe Zeymer, Gregory Y.H. Lip, Jurriën M. ten Berg, José Luis Navarro Estrada, Christopher P. Cannon, Ton Oude Ophuis, Corinna Miede, Stefan H. Hohnloser, Phillippe Gabriel Steg, Jonas Oldgren, Orly Leiva, Deepak L. Bhatt
Publikováno v:
EuroIntervention
Zeymer, U, Leiva, O, Hohnloser, S H, Steg, P G, Oldgren, J, Nickenig, G, Kiss, R G, Ongen, Z, Estrada, J N, Ophuis, T O, Lip, G Y H, Nordaby, M, Miede, C, ten Berg, J M, Bhatt, D L & Cannon, C P 2021, ' Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction : A post hoc analysis of the randomised RE-DUAL PCI trial ', EuroIntervention, vol. 17, no. 6, pp. 474-480 . https://doi.org/10.4244/EIJ-D-20-00799
Zeymer, U, Leiva, O, Hohnloser, S H, Steg, P G, Oldgren, J, Nickenig, G, Kiss, R G, Ongen, Z, Estrada, J N, Ophuis, T O, Lip, G Y H, Nordaby, M, Miede, C, ten Berg, J M, Bhatt, D L & Cannon, C P 2021, ' Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction : A post hoc analysis of the randomised RE-DUAL PCI trial ', EuroIntervention, vol. 17, no. 6, pp. 474-480 . https://doi.org/10.4244/EIJ-D-20-00799
Background: Little is known about the optimal antithrombotic therapy in patients with atrial fibrillation undergoing PCI for ST-elevation myocardial infarction (STEMI). Aims: The aim of this study was to investigate the safety and efficacy of dabigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0e8b8561c911a526d48133d49758e7
https://doi.org/10.4244/eij-d-20-00799
https://doi.org/10.4244/eij-d-20-00799